Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4535 | 1696 | 38.9 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
81 | 26583 | MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TEL AML1 | Author keyword | 47 | 64% | 3% | 47 |
2 | LEUKAEMIA CYTOGENET GRP | Address | 44 | 63% | 3% | 45 |
3 | ETV6 | Author keyword | 30 | 62% | 2% | 31 |
4 | ETV6 RUNX1 | Author keyword | 30 | 79% | 1% | 19 |
5 | TEL | Author keyword | 28 | 50% | 2% | 40 |
6 | T1221 | Author keyword | 23 | 72% | 1% | 18 |
7 | HOX11L2 | Author keyword | 18 | 83% | 1% | 10 |
8 | RIC TETTAMANTI | Address | 15 | 50% | 1% | 22 |
9 | TEL AML1 FUSION GENE | Author keyword | 14 | 100% | 0% | 7 |
10 | IKZF1 | Author keyword | 13 | 55% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TEL AML1 | 47 | 64% | 3% | 47 | Search TEL+AML1 | Search TEL+AML1 |
2 | ETV6 | 30 | 62% | 2% | 31 | Search ETV6 | Search ETV6 |
3 | ETV6 RUNX1 | 30 | 79% | 1% | 19 | Search ETV6+RUNX1 | Search ETV6+RUNX1 |
4 | TEL | 28 | 50% | 2% | 40 | Search TEL | Search TEL |
5 | T1221 | 23 | 72% | 1% | 18 | Search T1221 | Search T1221 |
6 | HOX11L2 | 18 | 83% | 1% | 10 | Search HOX11L2 | Search HOX11L2 |
7 | TEL AML1 FUSION GENE | 14 | 100% | 0% | 7 | Search TEL+AML1+FUSION+GENE | Search TEL+AML1+FUSION+GENE |
8 | IKZF1 | 13 | 55% | 1% | 16 | Search IKZF1 | Search IKZF1 |
9 | CRLF2 | 13 | 69% | 1% | 11 | Search CRLF2 | Search CRLF2 |
10 | E2A PBX1 | 12 | 50% | 1% | 18 | Search E2A+PBX1 | Search E2A+PBX1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TEL GENE | 133 | 73% | 6% | 103 |
2 | T12 21 | 123 | 77% | 5% | 85 |
3 | TEL AML1 FUSION | 77 | 76% | 3% | 54 |
4 | CRYPTIC T12 21 | 53 | 89% | 1% | 24 |
5 | T1 19Q23 P13 | 52 | 76% | 2% | 37 |
6 | ETS VARIANT GENE 6 | 52 | 100% | 1% | 18 |
7 | INTRACHROMOSOMAL AMPLIFICATION | 47 | 84% | 2% | 26 |
8 | TEL AML1 FUSION GENE | 44 | 88% | 1% | 21 |
9 | CRLF2 | 39 | 61% | 2% | 41 |
10 | TEL AML1 | 37 | 75% | 2% | 27 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Genomics in acute lymphoblastic leukaemia: insights and treatment implications | 2015 | 2 | 161 | 63% |
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update | 2011 | 206 | 132 | 19% |
The molecular basis of T cell acute lymphoblastic leukemia | 2012 | 71 | 127 | 37% |
Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine | 2015 | 1 | 100 | 69% |
The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia | 2012 | 26 | 153 | 69% |
Mechanisms of disease: Acute lymphoblastic leukemia | 2004 | 585 | 101 | 14% |
ETV6: A versatile player in leukemogenesis | 2005 | 92 | 99 | 54% |
Molecular genetics of B-precursor acute lymphoblastic leukemia | 2012 | 33 | 115 | 54% |
Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia | 2009 | 66 | 53 | 60% |
Origins of chromosome translocations in childhood leukaemia | 2003 | 316 | 133 | 20% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEUKAEMIA CYTOGENET GRP | 44 | 63% | 2.7% | 45 |
2 | RIC TETTAMANTI | 15 | 50% | 1.3% | 22 |
3 | LEUKAEMIA FUND CYTOGENET GRP | 12 | 75% | 0.5% | 9 |
4 | CHILDRENS CANC HAMBURG | 9 | 83% | 0.3% | 5 |
5 | PATHOL CLIN GENET | 8 | 75% | 0.4% | 6 |
6 | LEUKEMIA CYTOGENET GRP | 6 | 80% | 0.2% | 4 |
7 | LEUKEMIA BIOL GRP | 6 | 100% | 0.2% | 4 |
8 | PEDIAT CANC GENOME PROJECT | 4 | 44% | 0.4% | 7 |
9 | CLIN GENET CYTOGENET | 4 | 41% | 0.4% | 7 |
10 | LEUKAEMIA FUND | 3 | 13% | 1.2% | 21 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000208640 | ACUTE LYMPHOBLASTIC LEUKEMIA//MINIMAL RESIDUAL DISEASE//ACUTE LYMPHOBLASTIC LEUKAEMIA |
2 | 0.0000178276 | MLL//MLL GENE//11Q23 |
3 | 0.0000140366 | HAPLOID EMBRYONIC STEM CELLS//CHONGQING PIG IND SCI//INFLAMMATORY LEIOMYOSARCOMA |
4 | 0.0000131365 | TETRASOMY 8//NEAR TETRAPLOIDY//TRISOMY 4 |
5 | 0.0000119175 | IKAROS//AIOLOS//BCL11B |
6 | 0.0000116392 | HOX11//TLX 1//PRH |
7 | 0.0000106164 | DRS GENE//HEPATIC LEUKEMIA FACTOR//E2A HLF |
8 | 0.0000101239 | LMO4//LDB1//LMO2 |
9 | 0.0000100328 | RUNX3//AML1 ETO//AML1 |
10 | 0.0000085839 | NUP98//T711P15P15//DDX10 |